Calcinosis cutis, a debilitating deposition of calcium salts in the skin and subcutaneous tissues, is a frequent and challenging complication in patients with systemic sclerosis and other connective ...

EXTENSIVE clinical data have been accumulated during recent years that support the view that scleroderma is a systemic disease. In addition to cutaneous involvement, which remains the cardinal ...

Hydroxychloroquine appears to be a safe and effective treatment option for anogenital lichen sclerosus that only has mild adverse effects, according to a study published online July 19 in the ...

Which pulmonary manifestations were present among patients with connective tissue disorder? Pulmonary manifestations were found in about a quarter of connective tissue disorder (CTD) patients, ...

Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...

The increased deposition of connective tissue is a problem in chronic diseases of many organs such as the lungs (idiopathic pulmonary fibrosis), liver (cirrhosis), kidneys (kidney fibrosis), gut ...

Please provide your email address to receive an email when new articles are posted on . Keratoconus was associated with systemic manifestations of connective tissue hyperlaxity. A systemic underlying ...

A large systematic review and meta-analysis found an increased risk of various autoimmune and autoinflammatory connective tissue disorders among patients who had COVID-19 infection. The analysis ...

EULAR - The European Alliance of Associations for Rheumatology - has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) ...

The increased deposition of connective tissue is a problem in chronic diseases of many organs such as the lungs (idiopathic pulmonary fibrosis), liver (cirrhosis), kidneys (kidney fibrosis), gut ...